Vivo Capital, LLC
Annual return
—
SPY
—
Alpha
—
Invested
$1.2B
Holdings
45
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 41%. 2 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$ERAS
Erasca Inc
Q1 2026: Increased +31.0% (9.27M → 12.15M shares)
16.4%
02
$PRAX
Praxis Precision Medicines
Q1 2026: Increased +3.0% (328.9k → 338.9k shares)
9.1%
03
$TERN
Terns Pharmaceuticals Inc
Q1 2026: Sold 75.0% (5.35M → 1.33M shares)
5.9%
04
$TRVI
Trevi Therapeutics Inc
Q3 2025: Increased +13.5% (4.49M → 5.09M shares)
5.1%
05
$DBVT
DBV Technologies SA
Q1 2026: Increased +8.4% (2.46M → 2.67M shares)
4.7%
06
$CMPX
Compass Therapeutics Inc
Q3 2025: Increased +58.0% (6.04M → 9.55M shares)
4.2%
07
$TNGX
Tango Therapeutics Inc
Q4 2025: Increased +177.4% (776.7k → 2.15M shares)
3.8%
08
$SABS
SAB Biotherapeutics Inc
Q3 2025: New position (11.42M shares)
3.6%
09
$CRVS
Corvus Pharmaceuticals Holdings
Q1 2026: Increased +25.6% (2.23M → 2.81M shares)
3.4%
10
$DRUG
Bright Minds Biosciences Inc
Q1 2026: Increased +11.1% (501.6k → 557.2k shares)
3.4%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Last refreshed 08:10 UTC.